US$ 21.48
bpc 157 inecting int ofat BPC-157 For Knee Pain: Early Reported Outcomes, A report on intra-articular BPC-157 for knee pain described high rates of improvement: ~92% with BPC-157 alone, ~75% when combined with thymosin beta-4, Think twice before injecting peptides
Description
It is not approved by the Food and Drug Administration (FDA) for use in humans

This peptide was modified to increase its stability and antibacterial activity

Recent studies in humans, dogs, and cats suggest that oral supplementation is as equally effective as parenteral supplementation

we have treated thousands of patients of all ages
